Novaflux Technologies, Inc.

1 Wall Street
Princeton, NJ 08540

SBIR Award Summary

Total Number of Awards 29
Total Value of Awards $13MM
First Award Date 04/01/99
Most Recent Award Date 08/01/13

Key Personnel

Last Name Name Awards Contact
Lai Richard C Lai 3
Labib Mohamed E Labib 26 Message
Costerton John William Costerton 3
Stoodley Paul Stoodley 2
Stockel Richard F. Stockel 3 Message

29 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 08/01/13 - 07/31/14

DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in dialysis patients due to exposure to endotoxin has become a central issue in nephrology. The European Renal Association urges the routine use of ultrapure dialysate with bacteria and endotoxin levels of <0.1 CFU/ml and <0.03 EU/ml, respectivel...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 08/01/12 - 07/31/13

DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in dialysis patients due to exposure to endotoxin has become a central issue in nephrology. The European Renal Association urges the routine use of ultrapure dialysate with bacteria and endotoxin levels of <0.1 CFU/ml and <0.03 EU/ml, respectivel...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/15/11 - 07/31/12

DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in dialysis patients due to exposure to endotoxin has become a central issue in nephrology. The European Renal Association urges the routine use of ultrapure dialysate with bacteria and endotoxin levels of <0.1 CFU/ml and <0.03 EU/ml, respectivel...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 05/01/11 - 04/30/13

DESCRIPTION (provided by applicant): We discovered a new modality that will allow us to effectively remove excess fluid from patients and manage hypervolemia. Accordingly, we propose the development of a simple, safe miniature portable device that can slowly remove sufficient excess fluid, on a continuous basis, from patients with congestive hea...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 08/18/10 - 04/30/11

DESCRIPTION (provided by applicant): We discovered a new modality that will allow us to effectively remove excess fluid from patients and manage hypervolemia. Accordingly, we propose the development of a simple, safe miniature portable device that can slowly remove sufficient excess fluid, on a continuous basis, from patients with congestive hea...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/01/10 - 07/31/11

DESCRIPTION (provided by applicant): Over one-quarter of all oral antibiotics prescribed in the United States are for acute otitis media. Tympanostomy tube (TT) insertion has become the treatment of choice for children with recurrent or chronic otitis media, with more than two million tubes sold annually in the US. Tympanostomy is the most commo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/17/09 - 07/31/10

DESCRIPTION (provided by applicant): Over one-quarter of all oral antibiotics prescribed in the United States are for acute otitis media. Tympanostomy tube (TT) insertion has become the treatment of choice for children with recurrent or chronic otitis media, with more than two million tubes sold annually in the US. Tympanostomy is the most commo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/08 - 07/31/10

DESCRIPTION (provided by applicant): Since inadequate cleaning is the main cause of failure in sterilizing flexible endoscopes, cardinal modification of existing cleaning methods is urgently needed. During the Phase I (Grant # 1R43DK58622-01) and Phase II (Grant # 2R44DK58622-02) studies, Novaflux developed processes and devices based on its nov...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-06
Budget: 07/01/08 - 06/30/10

DESCRIPTION (provided by applicant): Existing dialyzer reprocessing methods should be re-examined by including additional requirements to ensure effective recovery of middle solute clearance for every dialysis treatment. Thus, cardinal modifications of dialyzer reprocessing technology are urgently needed to satisfy effective clearance of various...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/07 - 07/31/08

DESCRIPTION (provided by applicant): Since inadequate cleaning is the main cause of failure in sterilizing flexible endoscopes, cardinal modification of existing cleaning methods is urgently needed. During the Phase I (Grant # 1R43DK58622-01) and Phase II (Grant # 2R44DK58622-02) studies, Novaflux developed processes and devices based on its nov...

Load More